ROBERT J ISRAEL Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT J ISRAEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT J ISRAEL. ROBERT J ISRAEL is Executive Vice President, Medi in PROGENICS PHARMACEUTICALS INC ($PGNX) and Senior VP Medical Affairs in PROGENICS PHARMACEUTICALS INC ($PGNX) and SR. VP Medical Affairs in PROGENICS PHARMACEUTICALS INC ($PGNX) and Sr. VP, Medical Affairs in PROGENICS PHARMACEUTICALS INC ($PGNX).
ROBERT J ISRAEL in PROGENICS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT J ISRAEL: Executive Vice President, Medi, Senior VP Medical Affairs, Sr. VP, Medical Affairs, SR. VP Medical Affairs
Holdings: 35,050 shares
Current Value: $334,027
Latest Transaction: Jan 13 2015
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT J ISRAEL in PROGENICS PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2015 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | M | 5.33 | 2,000 | 10,660 | 8,000 | |
| Jan 13 2015 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Sell | S | 7.06 | 2,000 | 14,112 | 35,050 | 37.1 K to 35.1 K (-5.40 %) |
| Jan 13 2015 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Buy | M | 5.33 | 2,000 | 10,660 | 37,050 | 35.1 K to 37.1 K (+5.71 %) |
| Dec 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | M | 5.35 | 3,000 | 16,050 | 18,000 | |
| Dec 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Sell | S | 7.07 | 3,000 | 21,201 | 35,050 | 38.1 K to 35.1 K (-7.88 %) |
| Dec 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Buy | M | 5.35 | 3,000 | 16,050 | 38,050 | 35.1 K to 38.1 K (+8.56 %) |
| Nov 21 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | M | 5.35 | 9,000 | 48,150 | 21,000 | |
| Nov 21 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Sell | S | 7.00 | 9,000 | 63,000 | 35,050 | 44.1 K to 35.1 K (-20.43 %) |
| Nov 21 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Buy | M | 5.35 | 9,000 | 48,150 | 44,050 | 35.1 K to 44.1 K (+25.68 %) |
| Nov 14 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 10,000 | |
| Nov 14 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Sell | S | 6.83 | 10,000 | 68,300 | 35,050 | 45.1 K to 35.1 K (-22.20 %) |
| Nov 14 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Buy | M | 5.33 | 10,000 | 53,300 | 45,050 | 35.1 K to 45.1 K (+28.53 %) |
| Nov 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | M | 5.03 | 5,000 | 25,150 | 55,000 | |
| Nov 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Sell | S | 6.53 | 5,000 | 32,650 | 35,050 | 40.1 K to 35.1 K (-12.48 %) |
| Nov 12 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Buy | M | 5.03 | 5,000 | 25,150 | 40,050 | 35.1 K to 40.1 K (+14.27 %) |
| Mar 04 2014 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Executive Vice Pres ... | Option Exercise | A | 4.70 | 66,000 | 310,200 | 66,000 | |
| Jul 22 2013 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 5,000 | 26,650 | 20,000 | |
| Jul 22 2013 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 5,000 | 31,650 | 35,050 | 40.1 K to 35.1 K (-12.48 %) |
| Jul 22 2013 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 5,000 | 26,650 | 40,050 | 35.1 K to 40.1 K (+14.27 %) |
| Apr 08 2013 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | A | 5.03 | 60,000 | 301,800 | 60,000 | |
| Jul 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 25,000 | |
| Jul 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 9.79 | 1,000 | 9,790 | 35,050 | 36.1 K to 35.1 K (-2.77 %) |
| Jul 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 36,050 | 35.1 K to 36.1 K (+2.85 %) |
| Jun 22 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | D | 8.58 | 3,333 | 28,604 | 35,050 | 38.4 K to 35.1 K (-8.68 %) |
| Jun 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 26,000 | |
| Jun 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 8.51 | 1,000 | 8,508 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Jun 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| May 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 27,000 | |
| May 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 10.93 | 1,000 | 10,927 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| May 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Apr 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 28,000 | |
| Apr 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 9.85 | 1,000 | 9,852 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Apr 03 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Mar 05 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | A | 9.81 | 50,000 | 490,500 | 50,000 | |
| Mar 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 29,000 | |
| Mar 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 9.82 | 1,000 | 9,817 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Mar 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Feb 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 30,000 | |
| Feb 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 9.48 | 1,000 | 9,478 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Feb 02 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Jan 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 31,000 | |
| Jan 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 8.78 | 1,000 | 8,780 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Jan 04 2012 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Dec 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 32,000 | |
| Dec 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.66 | 1,000 | 6,660 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Dec 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Nov 01 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 33,000 | |
| Nov 01 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 1,000 | 6,330 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Nov 01 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Oct 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 34,000 | |
| Oct 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 1,000 | 6,330 | 38,383 | 39.4 K to 38.4 K (-2.54 %) |
| Oct 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 39,383 | 38.4 K to 39.4 K (+2.61 %) |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 4.62 | 3,638 | 16,822 | 0 | |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Payment of Exercise | F | 5.44 | 3,290 | 17,898 | 38,383 | 41.7 K to 38.4 K (-7.89 %) |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 4.62 | 3,638 | 16,822 | 41,673 | 38 K to 41.7 K (+9.56 %) |
| Sep 28 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 746 | 3,976 | 35,000 | |
| Sep 28 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 746 | 4,722 | 37,843 | 38.6 K to 37.8 K (-1.93 %) |
| Sep 28 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 746 | 3,976 | 38,589 | 37.8 K to 38.6 K (+1.97 %) |
| Sep 21 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 100 | 533 | 35,746 | |
| Sep 21 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 100 | 633 | 37,843 | 37.9 K to 37.8 K (-0.26 %) |
| Sep 21 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 100 | 533 | 37,943 | 37.8 K to 37.9 K (+0.26 %) |
| Sep 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 154 | 821 | 35,846 | |
| Sep 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 154 | 975 | 37,843 | 38 K to 37.8 K (-0.41 %) |
| Sep 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 154 | 821 | 37,997 | 37.8 K to 38 K (+0.41 %) |
| Aug 12 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 36,000 | |
| Aug 12 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 6.33 | 1,000 | 6,330 | 37,843 | 38.8 K to 37.8 K (-2.57 %) |
| Aug 12 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 38,843 | 37.8 K to 38.8 K (+2.64 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | A | 7.40 | 70,000 | 518,000 | 70,000 | |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 37,000 | |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.46 | 8,322 | 45,438 | 0 | |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Payment of Exercise | F | 7.40 | 6,930 | 51,282 | 37,843 | 44.8 K to 37.8 K (-15.48 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.46 | 8,322 | 45,438 | 44,773 | 36.5 K to 44.8 K (+22.83 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 7.21 | 1,000 | 7,205 | 36,151 | 37.2 K to 36.2 K (-2.69 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 37,151 | 36.2 K to 37.2 K (+2.77 %) |
| Jun 22 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 7.02 | 7,889 | 55,341 | 36,151 | 44 K to 36.2 K (-17.91 %) |
| Jun 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 38,000 | |
| Jun 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Sell | S | 8.15 | 1,000 | 8,153 | 44,040 | 45 K to 44 K (-2.22 %) |
| Jun 02 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Senior VP Medical A ... | Buy | M | 5.33 | 1,000 | 5,330 | 45,040 | 44 K to 45 K (+2.27 %) |
| May 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 39,000 | |
| May 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 7.39 | 1,000 | 7,390 | 44,040 | 45 K to 44 K (-2.22 %) |
| May 04 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 1,000 | 5,330 | 45,040 | 44 K to 45 K (+2.27 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 1,000 | 5,330 | 40,000 | |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 6.18 | 2,872 | 17,749 | 2,872 | |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.05 | 3,332 | 16,827 | 0 | |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 6.29 | 2,913 | 18,323 | 44,040 | 47 K to 44 K (-6.20 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.05 | 3,332 | 16,827 | 46,953 | 43.6 K to 47 K (+7.64 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 6.33 | 1,000 | 6,330 | 43,377 | 44.4 K to 43.4 K (-2.25 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 1,000 | 5,330 | 44,377 | 43.4 K to 44.4 K (+2.31 %) |
| Mar 30 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 800 | 4,264 | 41,000 | |
| Mar 30 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 6.33 | 800 | 5,064 | 43,377 | 44.2 K to 43.4 K (-1.81 %) |
| Mar 30 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 800 | 4,264 | 44,177 | 43.4 K to 44.2 K (+1.84 %) |
| Mar 09 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 200 | 1,066 | 41,800 | |
| Mar 09 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 6.33 | 200 | 1,266 | 43,377 | 43.6 K to 43.4 K (-0.46 %) |
| Mar 09 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 200 | 1,066 | 43,577 | 43.4 K to 43.6 K (+0.46 %) |
| Feb 08 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 7,597 | 40,492 | 42,000 | |
| Feb 08 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 6.33 | 7,597 | 48,089 | 43,377 | 51 K to 43.4 K (-14.90 %) |
| Feb 08 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 7,597 | 40,492 | 50,974 | 43.4 K to 51 K (+17.51 %) |
| Jan 20 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 403 | 2,148 | 49,597 | |
| Jan 20 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 6.33 | 403 | 2,551 | 43,377 | 43.8 K to 43.4 K (-0.92 %) |
| Jan 20 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 403 | 2,148 | 43,780 | 43.4 K to 43.8 K (+0.93 %) |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.46 | 6,745 | 36,828 | 6,745 | |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 4.83 | 3,625 | 17,502 | 0 | |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.68 | 3,301 | 18,750 | 43,377 | 46.7 K to 43.4 K (-7.07 %) |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 4.83 | 3,625 | 17,502 | 46,678 | 43.1 K to 46.7 K (+8.42 %) |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.05 | 3,332 | 16,827 | 3,332 | |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 4.32 | 8,786 | 37,938 | 0 | |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.08 | 7,945 | 40,361 | 42,851 | 50.8 K to 42.9 K (-15.64 %) |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 4.32 | 8,786 | 37,938 | 50,796 | 42 K to 50.8 K (+20.91 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.35 | 30,000 | 160,500 | 30,000 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.48 | 3,070 | 16,824 | 3,070 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 4.44 | 3,590 | 15,940 | 0 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Grant | A | 0.00 | 10,000 | 0 | 41,792 | 31.8 K to 41.8 K (+31.45 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.35 | 3,223 | 17,243 | 31,792 | 35 K to 31.8 K (-9.20 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 4.44 | 3,590 | 15,940 | 35,015 | 31.4 K to 35 K (+11.42 %) |
| Jun 24 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 5.82 | 6,180 | 35,961 | 31,186 | 37.4 K to 31.2 K (-16.54 %) |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.33 | 2,990 | 15,937 | 2,990 | |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 4.56 | 3,518 | 16,028 | 0 | |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.36 | 3,201 | 17,157 | 37,366 | 40.6 K to 37.4 K (-7.89 %) |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 4.56 | 3,518 | 16,028 | 40,567 | 37 K to 40.6 K (+9.50 %) |
| Mar 18 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 5.37 | 7,056 | 37,891 | 36,842 | 43.9 K to 36.8 K (-16.07 %) |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 4.44 | 8,094 | 35,937 | 8,094 | |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 3.78 | 4,223 | 15,976 | 0 | |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 4.45 | 3,843 | 17,101 | 43,898 | 47.7 K to 43.9 K (-8.05 %) |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 3.78 | 4,223 | 15,976 | 47,741 | 43.5 K to 47.7 K (+9.70 %) |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.24 | 3,042 | 15,940 | 3,042 | |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 4.26 | 3,578 | 15,239 | 0 | |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.01 | 3,256 | 16,313 | 43,270 | 46.5 K to 43.3 K (-7.00 %) |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 4.26 | 3,578 | 15,239 | 46,526 | 42.9 K to 46.5 K (+8.33 %) |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.33 | 50,000 | 266,500 | 50,000 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.33 | 8,210 | 43,759 | 0 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 5.15 | 3,095 | 15,939 | 3,095 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 5.33 | 7,471 | 39,820 | 42,738 | 50.2 K to 42.7 K (-14.88 %) |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.33 | 8,210 | 43,759 | 50,209 | 42 K to 50.2 K (+19.55 %) |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 6.59 | 2,418 | 15,935 | 2,418 | |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 5.65 | 2,845 | 16,074 | 0 | |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 5.65 | 2,845 | 16,074 | 41,785 | 38.9 K to 41.8 K (+7.31 %) |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 6.65 | 2,588 | 17,210 | 38,940 | 41.5 K to 38.9 K (-6.23 %) |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 10.31 | 2,758 | 28,435 | 2,758 | |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 9.13 | 1,819 | 16,607 | 0 | |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 10.74 | 1,654 | 17,764 | 41,360 | 43 K to 41.4 K (-3.85 %) |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 9.13 | 1,819 | 16,607 | 43,014 | 41.2 K to 43 K (+4.42 %) |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | A | 13.31 | 1,197 | 15,932 | 1,197 | |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 6.53 | 2,441 | 15,940 | 0 | |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Payment of Exercise | F | 13.93 | 1,663 | 23,166 | 41,088 | 42.8 K to 41.1 K (-3.89 %) |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 6.53 | 2,441 | 15,940 | 42,751 | 40.3 K to 42.8 K (+6.06 %) |
| Sep 04 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 12.29 | 1,000 | 12,290 | 25,000 | |
| Sep 04 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 15.00 | 1,000 | 15,000 | 39,801 | 40.8 K to 39.8 K (-2.45 %) |
| Sep 04 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Buy | M | 12.29 | 1,000 | 12,290 | 40,801 | 39.8 K to 40.8 K (+2.51 %) |
| Aug 05 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Option Exercise | M | 12.29 | 1,000 | 12,290 | 26,000 | |
| Aug 05 2008 | PGNX | PROGENICS PHARMACE ... | ISRAEL ROBERT J | Sr. VP, Medical Aff ... | Sell | S | 16.47 | 1,000 | 16,465 | 39,801 | 40.8 K to 39.8 K (-2.45 %) |